Article
Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival.
Drug design, development and therapy - 1 Jan 2019
Giordano Francesca, Naimo Giuseppina Daniela, Nigro Alessandra, Romeo Francesco, Paolì Alessandro, De Amicis Francesca, Vivacqua Adele, Morelli Catia, Mauro Loredana, Panno Maria Luisa
Abstract excerpt
PURPOSE: Neuroendocrine differentiation of prostate cancer, induced by androgen deprivation therapy, is mainly related to advanced disease and poor clinical outcome. Genetic and epigenetic alterations are the key elements of the prostate carcinogenesis. A group of compounds able to induce changes in this sense is inhibitors of histone deacetylase, to which it belongs valproic acid (VPA). In the present paper, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
